Glioblastoma: all 1,951 studies

Page 3 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.

• The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
• Impact of Salovum® and SPC® Flakes on Brain Tumor Induced EdemaRecruitingNCT06710249Phase 2
• WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma PatientsNot yet recruitingNCT06691308Early Phase 1
• Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant TumorsEnrolling by invitationNCT06690216Phase 1/2
• Injection of Active Allogeneic Natural Killer Cells in Patients With GliomasRecruitingNCT06687681Phase 2
• Optimizing Cytokine-Induced Killer Cells in Glioblastoma PatientsNot yet recruitingNCT06684899
• Expanded Access Program for GBM SubjectsAvailableNCT06676891
• A Phase I/II Study of IVONESCIMAB in Recurrent GlioblastomaRecruitingNCT06672575Phase 1/2
• Artificial Intelligence-Guided Radiotherapy Planning for GlioblastomaNot yet recruitingNCT06657027
• G-CSF After Chemo-radiation in Patients With GlioblastomaRecruitingNCT06649851Phase 2
• PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
• Anti-GD2 ADC M3554 in Advanced Solid TumorsRecruitingNCT06641908Phase 1
• TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and MeningiomasRecruitingNCT06640582Phase 1/2
• 5G-RUBY: Avutometinib and Defactinib in Malignant Brain TumoursRecruitingNCT06630260Phase 1/2
• Key Longitudinal Associations With Risk and Glioblastoma OutcomesRecruitingNCT06625684
• Extensive Resection of Malignant Brain Tumors Using Advanced Imaging TechniquesRecruitingNCT06623565Not applicable
• New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a StudyRecruitingNCT06622434Phase 1/2
• Pilot IntraOperative Neuronal Electrophysiology in Tumor rElatEd suRgeryRecruitingNCT06617208Not applicable
• The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBMEnrolling by invitationNCT06616727Phase 1
• Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of GlioblastomaRecruitingNCT06613841Early Phase 1
• Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/2
• A Study of BL-B01D1 in Patients With Recurrent GlioblastomaRecruitingNCT06598787Phase 2
• JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)RecruitingNCT06595186Phase 2
• Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant GliomaRecruitingNCT06585527Phase 1
• OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd TrialRecruitingNCT06558214Phase 2
• EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaRecruitingNCT06556563Phase 3
• A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type GlioblastomaRecruitingNCT06552260Early Phase 1
• Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)RecruitingNCT06551909Not applicable
• Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot TrialRecruitingNCT06533163Not applicable
• Targeted Survivin DC Cell Injection for the Treatment of GBMNot yet recruitingNCT06524063Phase 1
• Personalized Targeted Glioblastoma Therapies by ex Vivo Drug ScreeningRecruitingNCT06512311Not applicable
• A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsRecruitingNCT06496971Phase 3
• Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence WorkflowRecruitingNCT06492486Phase 2
• FET-PET-Guided Management of Pseudoprogression in GlioblastomaNot yet recruitingNCT06480721Not applicable
• Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) PatientsNot yet recruitingNCT06477939Phase 3
• Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]RecruitingNCT06466031Not applicable
• D2C7-IT + 2141-V11 Combination Post-resection in rGBMRecruitingNCT06455605Phase 1
• PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With GlioblastomaNot yet recruitingNCT06448286Phase 3
• Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed GlioblastomaRecruitingNCT06430424
• Lomustine in Addition to Standard of Care in Patients With MGMT Methylated GlioblastomaRecruitingNCT06419946Phase 3
• Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With GlioblastomaRecruitingNCT06418113Phase 1
• Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent GlioblastomaRecruitingNCT06410248Phase 1
• Expanded Access to Gallium Maltolate (GaM)AvailableNCT06404034
• Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck CancerRecruitingNCT06385132
• Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant GlioblastomaNot yet recruitingNCT06368934Not applicable
• Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing GlioblastomaRecruitingNCT06356883Phase 2
• TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.RecruitingNCT06353360Phase 2
• Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related AggressivenessRecruitingNCT06348693
• Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaRecruitingNCT06344130Phase 1
• Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionRecruitingNCT06333899Early Phase 1
• Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of GlioblastomaRecruitingNCT06327451Phase 2
• Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE TrialRecruitingNCT06319027Phase 2
• Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).RecruitingNCT06297512Phase 2
• The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)RecruitingNCT06283927
• Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent GlioblastomaRecruitingNCT06279767Phase 1/2
• The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaRecruitingNCT06273176
• NanoTherm In Adjuvant Therapy of Glioblastoma MultiformeRecruitingNCT06271421Not applicable
• Niraparib and Temozolomide in Patients GlioblastomaNot yet recruitingNCT06258018Phase 1/2
• Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNot yet recruitingNCT06241391Not applicable
• Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed GlioblastomaRecruitingNCT06222138Not applicable
• The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent GlioblastomaRecruitingNCT06220552Phase 2
• The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBMNot yet recruitingNCT06218524Phase 2
• The Safety and Effectiveness of NV-A01 in Glioma PatientsRecruitingNCT06193538Phase 1
• Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated GlioblastomaNot yet recruitingNCT06186440Phase 1/2
• Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T CellsRecruitingNCT06186401Phase 1
• Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of GlioblastomaRecruitingNCT06183983Not applicable
• Lerapolturev (PVSRIPO) in GBMRecruitingNCT06177964Phase 2
• PH Sensitive MRI Based Resections of GlioblastomaRecruitingNCT06176066Phase 1
• Study of Olutasidenib and Temozolomide in HGGRecruitingNCT06161974Phase 2
• PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsRecruitingNCT06161519Phase 1/2
• Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor PrognosisRecruitingNCT06160596
• Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent GlioblastomaRecruitingNCT06160206Phase 2
• The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)RecruitingNCT06146738
• The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)RecruitingNCT06146725
• Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined with Radiochemotherapy and Maintenance Chemotherapy in Patients with Glioblastoma (Brain-RF)RecruitingNCT06140875Not applicable
• Preoperative Preradiotherapy TTFieldsRecruitingNCT06136611Not applicable
• Immunotherapy Targeting of Cytomegalovirus Antigens in GlioblastomaRecruitingNCT06132438Phase 1
• The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)RecruitingNCT06118723
• Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.RecruitingNCT06113705Not applicable
• A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With GlioblastomaRecruitingNCT06102525Phase 1/2
• Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable GlioblastomaRecruitingNCT06090903Not applicable
• A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or FusionsRecruitingNCT06072586Early Phase 1
• A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB TrialRecruitingNCT06069726Phase 2
• Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma CellsRecruitingNCT06059690Phase 1/2
• Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerRecruitingNCT06058988Phase 2
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
• MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)RecruitingNCT06041555
• Sonodynamic Therapy in Patients With Recurrent GBMRecruitingNCT06039709Phase 1
• Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFieldsNot yet recruitingNCT06017063Not applicable
• A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse GliomaRecruitingNCT06016452Phase 2
• Predictive Value of Soluble CD146 in Glioblastoma PatientsRecruitingNCT06001281Not applicable
• Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma PatientsRecruitingNCT05990556Not applicable
• Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and AdhesionRecruitingNCT05990244Not applicable
• Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)RecruitingNCT05979064Not applicable
• Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
• A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical ResearchNot yet recruitingNCT05958485
• MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion AssessmentRecruitingNCT05957679Not applicable
• Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of AgeRecruitingNCT05956821Phase 1/2
• Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaRecruitingNCT05954858Not applicable
• A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2

← Glioblastoma overview